INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)
$1.46 -0.04 (-2.6667%)
Analysed INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) News Sources
Innate Pharma SA (IPHA) (Q2 2026) Earnings Call Highlights: Strategic Partnerships and Pipeline ...
17-08-2026
yahoo.com
Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
02-09-2026
yahoo.com
Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update
10-09-2026
yahoo.com
Sobi and Innate announce partnership is now effective following completion of closing conditions
17-09-2026
yahoo.com
Innate Pharma Reports First Half 2026 Business Update and Financial Results
17-09-2026
yahoo.com
Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?
23-09-2026
yahoo.com
Innate Pharma (IPHA) Upgraded to Buy: Here's What You Should Know
23-09-2026
yahoo.com
Down 22% in 4 Weeks, Here's Why Innate Pharma (IPHA) Looks Ripe for a Turnaround
08-10-2026
yahoo.com
Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update
20-10-2026
yahoo.com
Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
21-10-2026
yahoo.com
What is the current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?
The current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is $1.46.
INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) absolute price change since previous trading day?
The absolute price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is $-0.04.
INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) percentage price change since previous trading day?
The percentage price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is -2.6667%.
What is the most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?
The most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?
The most recent sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is .
SEC-8K** Filing Available For INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.